Orchiopexy fixes the testis in an appropriate position while preserving it; it is not orchiectomy or vas deferens interruption; to select this alternative the report would need repositioning and fixation of testis, whereas it identifies complete removal of one testis.

Hydrocelectomy addresses fluid around the testis by operative treatment of the sac; it is distinct from testicular removal; the controlling finding is complete removal of one testis, which is distinct from surgical correction of fluid sac surrounding testis.

Varicocelectomy refers to ligation or repair of abnormally dilated scrotal veins, not testicle fixation or removal, hydrocele surgery, or vasectomy, but the documented clinical work is complete removal of one testis; choosing it would misclassify the documented encounter.

Rhizotomy interrupts selected nerve fibers for pain control; it is not microsurgical decompression of a vessel against the nerve; to select this alternative the report would need deliberate lesioning of trigeminal sensory fibers, whereas it identifies separation of compressing vessel from trigeminal nerve.

This alternative, Direct repair of injured facial nerve, concerns microsurgical repair of a facial nerve injury instead of rhizotomy, nerve-tumor removal, vascular decompression, or deep-brain electrode placement; the alternative is not supported by the documented separation of compressing vessel from trigeminal nerve.

Excision of a cranial nerve tumor is surgical mass removal, unlike functional electrical stimulation or an ablative rhizotomy; surgical approach and tumor anatomy matter; the operative or visit note documents separation of compressing vessel from trigeminal nerve instead of resection of neoplasm arising from cranial nerve.

Ultrasound guidance documents real-time localization of a needle; separate reportability depends on whether guidance is included in the underlying procedure descriptor; the reported work involves selective branch-artery catheter contrast study and does not establish sonographic visualization of needle placement.

Fluoroscopy provides real-time x-ray guidance during an intervention; some service descriptions already include it, requiring review before separate reporting; the documented detail of selective branch-artery catheter contrast study prevents classifying it as live radiographic tracking of intravascular catheter.

This alternative, Stereotactic mammographic localization, concerns mammography-based targeting of a breast lesion rather than CT, ultrasound, fluoroscopy, or selective vascular angiography guidance; the alternative is not supported by the documented selective branch-artery catheter contrast study.

Reticulocyte testing assesses red-cell production dynamics rather than routine leukocyte differential or coagulation status; the quantitative method determines the service; the chart records interpretive review of peripheral smear morphology rather than measurement of immature red blood cell fraction.

A CBC without differential excludes a leukocyte differential; the coder should not upcode to a differential service merely because WBC count was measured; the operative or visit note documents interpretive review of peripheral smear morphology instead of CBC lacking white-cell differential.

Erythrocyte sedimentation rate corresponds to measurement of red-cell sedimentation in a calibrated tube rather than counting or morphologic assessment of blood cells; the record specifies interpretive review of peripheral smear morphology. Those details establish different classifications.

Tobacco cessation counseling has purpose and duration requirements; it differs from general preventive advice and from psychotherapy addressing psychiatric disorders; focused intervention to stop tobacco use is not recorded; the evidence points to structured diabetes self-care instruction.

Bariatric surgical consultation reflects evaluation for operative weight-loss treatment rather than counseling, diabetes education, or medical nutrition therapy, whereas the clinical note identifies structured diabetes self-care instruction; the different evidence changes the classification.

MNT reassessment reflects follow-up assessment and intervention; it is not the same category as an initial evaluation for an unestablished plan; this clinical evidence establishes structured diabetes self-care instruction, not follow-up modification of established nutrition plan.

ED visit code selection does not depend on office-style new/established patient distinctions; frequency of attendance alone does not select the level; the chart records clinically necessary collateral history for ED MDM rather than ED code family independent of patient history status.

The distinguishing evidence for Independent outpatient office consultation would be planned clinic assessment rather than the immediate ED-setting services or associated emergency MDM considerations; the described patient or procedure has clinically necessary collateral history for ED MDM, not those features.

ED E/M levels are selected by medical decision making rather than a physician's total minutes alone; the underlying reason for emergency care does not automatically determine intensity; the scenario instead describes clinically necessary collateral history for ED MDM, without demonstrating ED visit level grounded in MDM.

No necrotic muscle, fascial excision, or separate excisional work is documented, so a deep tissue-debridement family would be inaccurate.

Routine approximation or slight trimming is not creation of an adjacent tissue-transfer flap with separate secondary defect documentation.

Routine minor edge preparation performed to enable closure is integral to that repair. No independently documented excisional debridement service is described.

Injury seventh-character A often means active treatment, not necessarily the patient's first visit; timing alone cannot establish subsequent-healing status; this clinical evidence establishes mechanism of the traumatic event, not active treatment phase of injury.

A place-of-occurrence code gives contextual information where required or appropriate; it does not replace a fall-mechanism code or injury diagnosis; the scenario instead describes mechanism of the traumatic event, without demonstrating location of accident occurrence.

Injury sequela classification reflects residual effect after the acute injury and routine healing phase have ended, not active or subsequent healing encounters or circumstance codes, whereas the clinical note identifies mechanism of the traumatic event; the different evidence changes the classification.

The no-LUTS category contrasts with symptomatic BPH; do not infer obstruction or voiding complaints from gland enlargement alone; to select this alternative the report would need prostate enlargement without lower urinary tract symptoms, whereas it identifies confirmed UTI without site localization.

N18.30 is for stage 3 CKD not further specified; A single estimated GFR reading does not replace an appropriately documented stage; the operative or visit note documents confirmed UTI without site localization instead of provider-confirmed CKD stage 3 without subtype.

Selecting Acute cystitis would require clinician-diagnosed acute inflammatory infection of the bladder rather than unspecified-site UTI, stone, prostate enlargement, or chronic kidney disease; the actual document states confirmed UTI without site localization, which distinguishes the correct choice.

An excisional biopsy removes the lesion completely for diagnostic evaluation; determine whether the actual service is reported through excision rather than a separate biopsy code based on current CPT instructions; complete diagnostic removal of small lesion is not recorded; the evidence points to circular full-thickness diagnostic skin core.

Tangential biopsy obtains a superficial specimen for diagnosis, without asserting that the lesion was therapeutically removed in full; technique and purpose distinguish it from punch or incisional sampling; the controlling finding is circular full-thickness diagnostic skin core, which is distinct from superficial diagnostic specimen obtained tangentially.

The distinguishing evidence for Shave removal of a clinically benign lesion would be surface removal for treatment without the documentation that tissue sampling is performed as a diagnostic biopsy; the described patient or procedure has circular full-thickness diagnostic skin core, not those features.

Autograft is derived from the same patient, with harvest-site details potentially relevant to code reporting; it differs from donor-bank bone or synthetic graft material; the patient record supports bone harvest through separate pelvic incision rather than the alternative finding of patient's own cancellous bone moved to repair site.

Autologous cortical bone graft involves transfer of compact cortical bone from the patient rather than donor structural graft, cancellous chips, or synthetic substitute; the note describes bone harvest through separate pelvic incision instead, changing the applicable classification.

Synthetic substitutes are implanted materials, not harvested human bone; the product's characteristics and included services determine the coding treatment; what was actually documented is bone harvest through separate pelvic incision, not the different evidence of manufactured osteoconductive bone substitute.